European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.
Options
BORIS DOI
Date of Publication
January 2019
Publication Type
Article
Division/Institute
Author
Soar, Jasmeet | |
Perkins, Gavin D | |
Maconochie, Ian | |
Böttiger, Bernd W | |
Deakin, Charles D | |
Sandroni, Claudio | |
Olasveengen, Theresa M | |
Wyllie, Jonathan | |
Lockey, Andrew | |
Semeraro, Federico | |
Van de Voorde, Patrick | |
Lott, Carsten | |
Bossaert, Leo | |
Monsieurs, Koenraad G | |
Nolan, Jerry P |
Subject(s)
Series
Resuscitation
ISSN or ISBN (if monograph)
0300-9572
Publisher
Elsevier Science Ireland
Language
English
Publisher DOI
PubMed ID
30496838
Uncontrolled Keywords
Description
This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
Soar_Greif_cardiac arrest drugs_Resuscitation_2018.pdf | text | Adobe PDF | 402.46 KB | Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0) | accepted |